// company-profile
PharmaCyte Biotech, Inc.
PMCBExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.NVFilings21Insiders6
// api This PharmaCyte Biotech, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, PharmaCyte Biotech, Inc. insiders bought $0 across 4 transactions with no open-market sales.
- Most active insider: SCHECHTER JONATHAN with 1 transaction totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of PharmaCyte Biotech, Inc. as of 2026-03-31
Total reported AUM
$693,222
QoQ change
-3.0%
Reporting period
2026-03-31
#1
CITADEL ADVISORS LLC
CIK 1423053
$239,243
360K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$107,188
161K shares
#3
CITADEL ADVISORS LLC
CIK 1423053
$106,597
160K shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | SCHECHTER JONATHAN | PMCB | Award | 119,170 | $0.00 | $0K |
| Mar 31, 2026 | WEINSTEIN ROBERT | PMCB | Award | 119,170 | $0.00 | $0K |
| Mar 31, 2026 | WALKER WAYNE REMELL | PMCB | Award | 119,170 | $0.00 | $0K |
| Mar 31, 2026 | Abecassis Michael M | PMCB | Award | 119,170 | $0.00 | $0K |
| Jan 7, 2026 | Silverman Joshua | PMCB | Purchase | 40,000 | $0.83 | $33K |
29 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.